Back
Arcus Biosciences 10K Form
Sell
31
RCUS
Arcus Biosciences
Last Price:
$14.47
Seasonality Move:
9.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RCUS News And Ratings
See the #1 stock for the next 7 days that we like better than RCUS
RCUS Financial Statistics
Sales & Book Value
Annual Sales: | $117M |
---|---|
Cash Flow: | $25M |
Price / Cash Flow: | 0 |
Annual Sales: | $6.17 |
Price / Book: | 2.24 |
Profitability
EPS (TTM): | -3.15000 |
---|---|
Net Income (TTM): | $-270M |
Gross Margin: | -- |
Return on Equity: | -46.73% |
Return on Assets: | -22.44% |
Arcus Biosciences Earnings Forecast
Key Arcus Biosciences Financial Ratios
-
The Research & Development expenses have been 290.60% of Revenue.
-
The Net Earning history of RCUS is -262.39% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 1 years.
Arcus Biosciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | RCUS |
CUSIP: | 03969F |
Website: | arcusbio.com |
Debt
Debt-to-Equity Ratio: | 0.08 |
---|---|
Current Ratio: | 5.24 |
Quick Ratio: | 5.16 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
RCUS Technical Analysis vs Fundamental Analysis
Sell
31
Arcus Biosciences (RCUS)
is a Sell
Is Arcus Biosciences a Buy or a Sell?
-
Arcus Biosciences stock is rated a SellThe current Arcus Biosciences [RCUS] share price is $13.82. The Score for RCUS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.